Insider · CIK 0001962250
Harsha Murthy
Files at BICX (BioCorRx Inc.). First filing -, latest -.
In brief
Harsha Murthy files SEC Form 4 as director at BICX (BioCorRx Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Harsha Murthy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 14,153 | Apr 3, 2024 |
| Mar 28, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 19,719 | Apr 3, 2024 |
Questions about Harsha Murthy
Answered from the filings on this page, as of the latest one.
Is Harsha Murthy buying or selling?
Harsha Murthy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Harsha Murthy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Harsha Murthy has 0.
Where does Harsha Murthy file Form 4?
Harsha Murthy has filed Form 4 at BICX (BioCorRx Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.